Ozempic But Without The Needles? Pharma Giants Rush To Bring Weight Loss Drugs In Pill Form: WSJ
Portfolio Pulse from Benzinga Newsbot
Pharmaceutical companies Novo Nordisk, Eli Lilly, and Pfizer are developing pill versions of injectable weight-loss drugs like Ozempic to appeal to needle-averse patients and potentially cost less. Novo Nordisk is leading the race with a tablet form of semaglutide, a key ingredient in Ozempic, and plans to seek approval from US and European regulators later this year.
June 25, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly is working on developing a pill version of injectable weight-loss drugs like Ozempic, potentially appealing to needle-averse patients and costing less.
Eli Lilly's involvement in the development of pill versions of injectable weight-loss drugs could potentially expand its market reach and increase sales, as it appeals to needle-averse patients and potentially costs less. This could have a positive short-term impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Pfizer is working on developing a pill version of injectable weight-loss drugs like Ozempic, potentially appealing to needle-averse patients and costing less.
Pfizer's involvement in the development of pill versions of injectable weight-loss drugs could potentially expand its market reach and increase sales, as it appeals to needle-averse patients and potentially costs less. This could have a positive short-term impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50